Efficacy of a novel antibody-drug conjugate (ADC), ABT-414, as monotherapy in epidermal growth factor receptor (EGFR) amplified, recurrent glioblastoma (GBM). Conference Paper uri icon

authors

  • Van Den Bent, Martin J
  • Gan, Hui Kong
  • Lassman, Andrew B
  • Kumthekar, Priya
  • Merrell, Ryan
  • Butowski, Nicholas A
  • Lwin, Zarnie
  • Mikkelsen, Tom
  • Nabors, Louis B
  • Papadopoulos, Kyriakos P
  • Penas-Prado, Marta
  • Simes, John
  • Wheeler, Helen
  • Gomez, Erica J
  • Lee, Ho-Jin
  • Roberts-Rapp, Lisa
  • Xiong, Hao
  • Bain, Earle E
  • Holen, Kyle D
  • Reardon, David A

publication date

  • May 20, 2016